Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

COVID-19

COVID-19 Antibody Detection Study

Serological Surveillance for COVID-19 in Central North Carolina

Studies Seeking Participants Icon Studies Seeking Participants Location icon Residents of North Carolina 18+ Ages 18+ Gender Icon All Genders
COVID-19 antibody
  1. Home
  2. Studies
  3. COVID-19 Antibody Detection Study
  4. Study Overview

We protect our registrants' privacy

This yearlong study will test adult volunteers for antibodies in their blood that indicate exposure to SARS-CoV-2, the virus that causes COVID-19. Researchers hope to learn more about disease symptoms and how many antibodies stay in a person’s blood over the course of a year. This information will help inform public health efforts in the future.

Who Can Participate?

  • Adults 18 years or older.
  • Able to read and speak English.
  • Able to communicate via email.
  • Able to provide own transportation and travel to Research Triangle Park, North Carolina.
  • You can still enroll even if you received a COVID-19 vaccine. The antibodies detected by our study are produced by the COVID-19 disease rather than the vaccine.

What Is Required?

  • Telephone appointment.
  • Repeated visits are essential for the study. Over a year, participants will have five study visits to collect blood to test for antibodies. If you have antibodies, you will have nasal swabs to detect COVID-19 infection.
  • Completion of online medical history questionnaires and weekly symptom surveys.

Who Is Running the Study?

A team, led by Dr. Stavros Garantziotis, M.D., at the National Institute of Environmental Health Sciences (NIEHS) Clinical Research Unit in Research Triangle Park, North Carolina.

Lead Researchers

Stavros Garantziotis, M.D.

Stavros Garantziotis, M.D. is passionate about finding cures for chronic lung disease like asthma, COPD and pulmonary fibrosis. He believes that if we can understand the mechanism of disease development for every individual patient, we can design intelligent and effective treatment with less side effects. Dr. Garantziotis obtained his medical degree at the Albert-Ludwigs-University in Germany. He trained in Internal Medicine at the Albert Einstein College of Medicine in New York and in Pulmonary and Critical Care Medicine at Duke University Medical Center, where he was a faculty member before joining the NIEHS to direct the Clinical Research Unit.

Research Webpage

For More Information About This Study

  • Call: 1-855-MYNIEHS (1-855-696-4347)
  • Email: myniehs@nih.gov
  • Protocol Number: 20-E-0143

This content is available to use on your website.

Please visit NIEHS Syndication to get started.